Clin2
NCT05215704Possibly a fitRecruiting

Lab study of dormant HIV using samples from you

HIV InfectionsHIV-1-infectionHIV-2 Infection

Part of Immune system & allergy, Infections clinical trials.

This trial collects blood samples from people living with HIV to study dormant (inactive) HIV cells in the lab. The goal is to better understand how to target these hidden cells as part of an eventual cure.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older
  • You have a confirmed HIV-1 or HIV-2 infection
  • You can have blood drawn (phlebotomy) for the study
  • You can safely have a vein catheter placed (about 2.5 cm) if needed
  • You do not have major current health problems that make the study unsafe, such as severe symptomatic anemia or a recent major heart-related event
  • Your healthcare team agrees you’re able to take part based on your medical and personal situation

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05973825Recruiting
HIV blood study to study immune responses over many years

This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.

Ghent, Oost-Vlaanderen
NCT07692932Not yet recruiting
HIV cure study testing a new drug combination

This study tests whether giving two experimental drugs together can help your immune system find and destroy hidden HIV cells. It aims to see if this approach can reduce the amount of virus in your body even while you're on your regular HIV medications.

Brussels, Brussels Capital
NCT06441123Recruiting
A trial of a new HIV latency-reversing drug

This trial tests a new type of medicine that aims to wake up HIV hiding in your body's cells by targeting a viral protein called Tat. The goal is to help find a way to clear the virus completely.

Montpellier
NCT05584397Enrolling by invitation
Compare immune activity and HIV hidden reservoir on two treatments

This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.

Seattle, Washington
NCT05147519Recruiting
Observes HIV and other infections to learn who gets them

This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.

Kericho, Kericho County
NCT07656077Not yet recruiting
How HIV hides in gut tissue during treatment

This study looks at how HIV can stay hidden in the gut even when antiretroviral therapy keeps the virus under control. By examining tissue from a routine colonoscopy, researchers hope to learn more about why HIV persists, which could lead to better treatments.

Hear when a new HIV Infections trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.